New hope for rare tumors: experimental drug targets cancer cells
NCT ID NCT07129252
First seen Oct 31, 2025 · Last updated Apr 30, 2026 · Updated 23 times
Summary
This study tests a new drug called CRN09682 in people with advanced neuroendocrine tumors and other solid tumors that have spread. The drug works by targeting a specific protein on cancer cells to deliver a toxic payload. The goal is to find the safest dose and see if it can shrink or slow tumor growth. About 150 participants will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Crinetics Study Site
RECRUITINGDuarte, California, 91010, United States
-
Crinetics Study Site
RECRUITINGNewport Beach, California, 92663, United States
-
Crinetics Study Site
RECRUITINGOrange, California, 92868, United States
-
Crinetics Study Site
RECRUITINGSan Francisco, California, 60637, United States
-
Crinetics Study Site
RECRUITINGDenver, Colorado, 80218, United States
-
Crinetics Study Site
RECRUITINGNew Haven, Connecticut, 48201, United States
-
Crinetics Study Site
RECRUITINGAtlanta, Georgia, 30322, United States
-
Crinetics Study Site
RECRUITINGLexington, Kentucky, 40536, United States
-
Crinetics Study Site
RECRUITINGMetairie, Louisiana, 70006, United States
-
Crinetics Study Site
RECRUITINGGrand Rapids, Michigan, 49503, United States
-
Crinetics Study Site
RECRUITINGPhiladelphia, Pennsylvania, 19111, United States
-
Crinetics Study Site
RECRUITINGAustin, Texas, 78758, United States
-
Crinetics Study Site
RECRUITINGHouston, Texas, 70030, United States
-
Crinetics Study Site
RECRUITINGIrving, Texas, 75039, United States
-
Crinetics Study Site
RECRUITINGSalt Lake City, Utah, 84112, United States
-
Crinetics Study Site
RECRUITINGCharlottesville, Virginia, 22908, United States
-
Crinetics Study Site
RECRUITINGFairfax, Virginia, 22031, United States
-
Crinetics Study Site
RECRUITINGBarcelona, 08023, Spain
-
Crinetics Study Site
RECRUITINGBarcelona, 08035, Spain
-
Crinetics Study Site
RECRUITINGMadrid, 28040, Spain
-
Crinetics Study Site
RECRUITINGMadrid, 28041, Spain
Conditions
Explore the condition pages connected to this study.